col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Case Journals: Case Medical Research
  original article Date Title Authors   All Authors
1 [GO] 2020―Mar―12 Safety and Immunity of Covid-19 aAPC Vaccine
2 [GO] 2020―Mar―12 Accurate Classification System for Patients With COVID-19 Pneumonitis
3 [GO] 2020―Mar―12 Mental Health and Its Correlates Among Chinese Adolescents Exposed to the Novel Coronavirus Disease 2019
4 [GO] 2020―Mar―12 Novel Coronavirus Induced Severe Pneumonia Treated by Dental Pulp Mesenchymal Stem Cells
5 [GO] 2020―Mar―10 Prognostic Factors of Patients With COVID-19
6 [GO] 2020―Mar―10 Anti-SARS-CoV-2 Inactivated Convalescent Plasma in the Treatment of COVID-19
7 [GO] 2020―Mar―10 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Severe Coronavirus Disease (COVID-19)
8 [GO] 2020―Mar―10 The Efficacy and Safety of Huai er in the Adjuvant Treatment of COVID-19
9 [GO] 2020―Mar―10 Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734™) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment
10 [GO] 2020―Mar―10 Safety Related Factors of Endotracheal Intubation in Patients With Severe Covid-19 Pneumonia
11 [GO] 2020―Mar―10 Therapy for Pneumonia Patients iInfected by 2019 Novel Coronavirus
12 [GO] 2020―Mar―10 Clinical Progressive Characteristics and Treatment Effects of 2019-novel Coronavirus
13 [GO] 2020―Mar―10 Stem Cell Educator Therapy Treat the Viral Inflammation Caused by Severe Acute Respiratory Syndrome Coronavirus 2
14 [GO] 2020―Mar―10 Evaluation of Ganovo Combined With Ritonavir in the Treatment of Novel Coronavirus Infection
15 [GO] 2020―Mar―10 Multicenter Clinical Study on the Efficacy and Safety of Xiyanping Injection in the Treatment of New Coronavirus Infection Pneumonia (General and Severe)
16 [GO] 2020―Mar―10 Efficacy and Safety of IFN-α2β in the Treatment of Novel Coronavirus Patients
17 [GO] 2020―Mar―10 Multicenter Study on Nosocomial Transmission of SARS-CoV-2 Virus
18 [GO] 2020―Mar―01 Recombinant Human Angiotensin-converting Enzyme 2 (rhACE2) as a Treatment for Patients With COVID-19
19 [GO] 2020―Mar―01 The Clinical Study of Carrimycin on Treatment Patients With COVID-19
20 [GO] 2020―Mar―01 Treatment With Mesenchymal Stem Cells for Severe Corona Virus Disease 2019(COVID-19)
21 [GO] 2020―Mar―01 Eculizumab (Soliris) in Covid-19 Infected Patients
22 [GO] 2020―Feb―27 The Effect of T89 on Improving Oxygen Saturation and Clinical Symptoms in Patients With COVID-19
23 [GO] 2020―Feb―26 Safety and Immunogenicity Study of 2019-nCov Vaccine (mRNA-1273) to Treat Novel Coronavirus
24 [GO] 2020―Feb―26 Humanistic Care in Patients With Coronavirus Disease 2019
25 [GO] 2020―Feb―26 Humanistic Care in Healthcare Workers in Coronavirus Disease 2019
26 [GO] 2020―Feb―26 A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
27 [GO] 2020―Feb―26 Study for Novel Coronavirus Pneumonia (NCP)
28 [GO] 2020―Feb―26 CT Scores Predict Mortality in 2019-nCoV Pneumonia
29 [GO] 2020―Feb―25 A New Screening Strategy for 2019 Novel Coronavirus Infection
30 [GO] 2020―Feb―22 Fingolimod in COVID-19
31 [GO] 2020―Feb―22 The Investigation of the Neonates With or With Risk of COVID-19
32 [GO] 2020―Feb―22 Adaptive COVID-19 Treatment Trial
33 [GO] 2020―Feb―22 Detection of 2019 Novel Coronavirus in Multiple Organ System and Its Relationship With Clinical Manifestations
34 [GO] 2020―Feb―22 Clinical Features of Suspected and Confirmed Patients of 2019 Novel Coronavirus Infection
35 [GO] 2020―Feb―22 NK Cells Treatment for Novel Coronavirus Pneumonia
36 [GO] 2020―Feb―22 Treatment of Pulmonary Fibrosis Due to 2019-nCoV Pneumonia With Fuzheng Huayu
37 [GO] 2020―Feb―21 Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19
38 [GO] 2020―Feb―20 The COVID-19 Mobile Health Study (CMHS)
39 [GO] 2020―Feb―20 Bevacizumab in Severe or Critical Patients With COVID-19 Pneumonia
40 [GO] 2020―Feb―20 Xiyanping Injection for the Treatment of New Coronavirus Infected Pneumonia
41 [GO] 2020―Feb―20 A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia
42 [GO] 2020―Feb―20 Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia
43 [GO] 2020―Feb―20 Function and Safety Study of SARS-CoV-2 Synthetic Minigene Vaccines
44 [GO] 2020―Feb―20 Lopinavir/ Ritonavir, Ribavirin and IFN-beta Combination for nCoV Treatment
45 [GO] 2020―Feb―18 Clinical Characteristics and Long-term Prognosis of 2019-nCoV Infection in Children
46 [GO] 2020―Feb―18 Clinical Characteristics Difference Between the Hypertension Patients With and Without ACEI Treatment When Suffered With 2019-nCoV Infection in China
47 [GO] 2020―Feb―14 Umbilical Cord(UC)-Derived Mesenchymal Stem Cells(MSCs) Treatment for the 2019-novel Coronavirus(nCOV) Pneumonia
48 [GO] 2020―Feb―14 Immunoregulatory Therapy for 2019-nCoV
49 [GO] 2020―Feb―12 Vitamin C Infusion for the Treatment of Severe 2019-nCoV Infected Pneumonia
50 [GO] 2020―Feb―12 Treatment of Acute Severe 2019-nCoV Pneumonia With Immunoglobulin From Cured Patients
51 [GO] 2020―Feb―11 Evaluating and Comparing the Safety and Efficiency of ASC09/Ritonavir and Lopinavir/Ritonavir for Novel Coronavirus Infection
52 [GO] 2020―Feb―11 The Efficacy of Different Hormone Doses in 2019-nCoV Severe Pneumonia
53 [GO] 2020―Feb―08 Clinical Study of Arbidol Hydrochloride Tablets in the Treatment of Pneumonia Caused by Novel Coronavirus
54 [GO] 2020―Feb―08 Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection
55 [GO] 2020―Feb―08 A Survey of Psychological Status of Medical Workers and Residents in the Context of 2019 Novel Coronavirus Pneumonia
56 [GO] 2020―Feb―08 Efficacy and Safety of Hydroxychloroquine for Treatment of Pneumonia Caused by 2019-nCoV ( HC-nCoV )
57 [GO] 2020―Feb―08 The Efficacy of Intravenous Immunoglobulin Therapy for Severe 2019-nCoV Infected Pneumonia
58 [GO] 2020―Feb―08 A Randomized,Open,Controlled Clinical Study to Evaluate the Efficacy of ASC09F and Ritonavir for 2019-nCoV Pneumonia
59 [GO] 2020―Feb―07 Severe 2019-nCoV Remdesivir RCT
60 [GO] 2020―Feb―06 Mesenchymal Stem Cell Treatment for Pneumonia Patients Infected With 2019 Novel Coronavirus
61 [GO] 2020―Feb―06 The Efficacy of Lopinavir Plus Ritonavir and Arbidol Against Novel Coronavirus Infection
62 [GO] 2020―Feb―06 Washed Microbiota Transplantation for Patients With Coronavirus Pneumonia
63 [GO] 2020―Feb―06 Efficacy of a Self-test and Self-alert Mobile Applet in Detecting Susceptible Infection of 2019-nCoV
64 [GO] 2020―Feb―06 Efficacy and Safety of Darunavir and Cobicistat for Treatment of Pneumonia Caused by 2019-nCoV
65 [GO] 2020―Feb―06 Treatment and Prevention of Traditional Chinese Medicines (TCMs) on 2019-nCoV Infection
66 [GO] 2020―Feb―06 2019-nCoV Outbreak and Cardiovascular Diseases
67 [GO] 2020―Feb―06 A Prospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia
68 [GO] 2020―Feb―06 A Prospective,Randomized Controlled Clinical Study of Antiviral Therapy in the 2019-nCoV Pneumonia
69 [GO] 2020―Feb―06 Mild/Moderate 2019-nCoV Remdesivir RCT
70 [GO] 2020―Jan―30 A Randomized Multicenter Controlled Clinical Trial of Arbidol in Patients With 2019 Novel Coronavirus (2019-nCoV)
71 [GO] 2020―Jan―30 Development of a Simple, Fast and Portable Recombinase Aided Amplification Assay for 2019-nCoV
72 [GO] 2020―Jan―29 Glucocorticoid Therapy for Novel CoronavirusCritically Ill Patients With Severe Acute Respiratory Failure


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.012 sec